Golimumab for Treating Chronic Inflammatory Joint Diseases in the Adult Population: Clinical Efficacy and Tolerability

Autor:	Natal’ya N. Chichasova
Jazyk:	English<br />Russian
Rok vydání:	2019
Předmět:	rheumatoid arthritis psoriatic arthritis ankylosing spondylitis non-radiographic spondylitis golimumab efficacy tolerability pediatric rheumatology practice Pediatrics RJ1-570
Zdroj:	Вопросы современной педиатрии, Vol 17, Iss 6, Pp 449-457 (2019)
Druh dokumentu:	article
ISSN:	1682-5527 1682-5535
DOI:	10.15690/vsp.v17i6.1975
Popis:	Due to the recent introduction of golimumab into paediatric rheumatology practice, an overview of the clinical studies of this tumour necrosis factor alpha inhibitor, most of which were conducted with adult patients with rheumatic diseases, has been presented. Clinical laboratory effects and tolerability of golimumab in the form of subcutaneous injections have been analysed for rheumatoid arthritis, psoriatic arthritis, and spondylitis. Evaluation of the efficacy and tolerability of golimumab in long-term observational studies (up to 5 years) has been discussed.
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/93a208cab9824336883307773baeee1c Zobrazit plný text záznamu View record in DOAJ